SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001126234-21-000023
Filing Date
2021-02-18
Accepted
2021-02-18 16:22:11
Documents
2
Period of Report
2021-02-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_161368331801070.html 3  
1 FORM 3 wf-form3_161368331801070.xml 3 4196
2 VAN ES-JOHANSSON POA ex-24.htm EX-24 4374
  Complete submission text file 0001126234-21-000023.txt   10038
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Issuer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6863 BEE CAVE ROAD SUITE 200 AUSTIN TX 78736
Business Address
van Es-Johansson An (Reporting) CIK: 0001795902 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35342 | Film No.: 21649817